Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 07-Dec-23 5:18 PM View:  | Imran Talat Chief Executive Officer Director | Rani Therapeutics Holdings,... (RANI) | 06-Dec-23 | Private Purchase | 10,000 | $2.27 | $22,700.00 | 2% 474.45K to 484.45K | |
| 06-Dec-23 8:00 AM View: | Imran Talat Chief Executive Officer Director | Rani Therapeutics Holdings,... (RANI) | 04-Dec-23 | Private Purchase | 5,000 | $2.57 | $12,850.00 | 1% 469.45K to 474.45K | |
| 01-Dec-23 8:00 AM View: | Imran Talat Chief Executive Officer Director | Rani Therapeutics Holdings,... (RANI) | 29-Nov-23 | Private Purchase | 20,000 | $2.05 | $41,000.00 | 4% 449.45K to 469.45K | |
| 08-Dec-23 4:29 PM View: | Quiroga Cortes Isidoro Alfo... 10% Owner | Rani Therapeutics Holdings,... (RANI) | 24-Nov-23 | Sale | 5,265,160 | $2.01 | $10,583,000.00 | (100%) 5.27M to 8.4K | |
| 08-Dec-23 4:27 PM View: | South Cone Investments Limi... 10% Owner | Rani Therapeutics Holdings,... (RANI) | 24-Nov-23 | Private Purchase | 5,265,160 | $2.01 | $10,583,000.00 | 77% 6.87M to 12.13M | |
| 21-Nov-23 4:05 PM View: | Butel Jean Luc Director | Rani Therapeutics Holdings,... (RANI) | 17-Nov-23 | Private Purchase | 50,500 | $2.03 | $102,495.00 | 100% 0 to 50.5K | |
| 20-Nov-23 8:00 AM View: | Nanavaty Maulik Director | Rani Therapeutics Holdings,... (RANI) | 16-Nov-23 | Private Purchase | 500 | $1.98 | $990.00 | 5% 11.02K to 11.52K | |
| 09-Nov-23 4:05 PM View: | Imran Talat Chief Executive Officer Director | Rani Therapeutics Holdings,... (RANI) | 07-Nov-23 | Private Purchase | 5,000 | $2.00 | $9,975.00 | 1% 444.45K to 449.45K | |
| 15-May-23 4:22 PM View: | South Cone Investments Limi... 10% Owner | Rani Therapeutics Holdings,... (RANI) | 12-May-23 | Purchase | 2,645 | $3.98 | $10,529.50 | < 1% 6.86M to 6.87M | |
| 15-May-23 4:22 PM View: | South Cone Investments Limi... 10% Owner | Rani Therapeutics Holdings,... (RANI) | 11-May-23 | Private Purchase | 2,610 | $3.87 | $10,096.30 | < 1% 6.86M to 6.86M | |
| 10-May-23 4:25 PM View: | South Cone Investments Limi... 10% Owner | Rani Therapeutics Holdings,... (RANI) | 08-May-23 | Private Purchase | 4,420 | $4.46 | $19,733.10 | < 1% 6.86M to 6.86M | |
| 05-May-23 1:26 PM View: | South Cone Investments Limi... 10% Owner | Rani Therapeutics Holdings,... (RANI) | 03-May-23 | Private Purchase | 2,040 | $4.81 | $9,816.07 | < 1% 6.85M to 6.86M | |
| 02-May-23 1:09 PM View: | South Cone Investments Limi... 10% Owner | Rani Therapeutics Holdings,... (RANI) | 28-Apr-23 | Private Purchase | 2,173 | $4.71 | $10,225.10 | < 1% 6.85M to 6.85M | |
| 26-Apr-23 5:09 PM View: | South Cone Investments Limi... 10% Owner | Rani Therapeutics Holdings,... (RANI) | 25-Apr-23 | Purchase | 4,423 | $4.51 | $19,952.20 | < 1% 6.85M to 6.85M | |
| 26-Apr-23 5:09 PM View: | South Cone Investments Limi... 10% Owner | Rani Therapeutics Holdings,... (RANI) | 24-Apr-23 | Private Purchase | 4,280 | $4.67 | $19,994.40 | < 1% 6.84M to 6.85M | |
| 24-Apr-23 5:25 PM View: | South Cone Investments Limi... 10% Owner | Rani Therapeutics Holdings,... (RANI) | 21-Apr-23 | Purchase | 4,100 | $4.93 | $20,223.70 | < 1% 6.84M to 6.84M | |
| 24-Apr-23 5:25 PM View: | South Cone Investments Limi... 10% Owner | Rani Therapeutics Holdings,... (RANI) | 20-Apr-23 | Private Purchase | 1,850 | $5.32 | $9,850.51 | < 1% 6.84M to 6.84M | |
| 20-Apr-23 3:23 PM View: | South Cone Investments Limi... 10% Owner | Rani Therapeutics Holdings,... (RANI) | 18-Apr-23 | Private Purchase | 1,850 | $5.37 | $9,938.94 | < 1% 6.84M to 6.84M | |
| 18-Apr-23 1:50 PM View: | South Cone Investments Limi... 10% Owner | Rani Therapeutics Holdings,... (RANI) | 14-Apr-23 | Private Purchase | 1,901 | $5.27 | $10,019.00 | < 1% 6.83M to 6.84M | |
| 14-Apr-23 4:21 PM View: | South Cone Investments Limi... 10% Owner | Rani Therapeutics Holdings,... (RANI) | 13-Apr-23 | Purchase | 890 | $5.47 | $4,863.85 | < 1% 6.83M to 6.83M | |
| 14-Apr-23 4:21 PM View: | South Cone Investments Limi... 10% Owner | Rani Therapeutics Holdings,... (RANI) | 12-Apr-23 | Private Purchase | 3,577 | $5.48 | $19,585.10 | < 1% 6.83M to 6.83M | |
| 12-Apr-23 12:22 PM View: | South Cone Investments Limi... 10% Owner | Rani Therapeutics Holdings,... (RANI) | 11-Apr-23 | Purchase | 1,765 | $5.58 | $9,845.88 | < 1% 6.83M to 6.83M | |
| 12-Apr-23 12:22 PM View: | South Cone Investments Limi... 10% Owner | Rani Therapeutics Holdings,... (RANI) | 10-Apr-23 | Private Purchase | 1,923 | $5.07 | $9,744.23 | < 1% 6.83M to 6.83M | |
| 10-Apr-23 1:54 PM View: | South Cone Investments Limi... 10% Owner | Rani Therapeutics Holdings,... (RANI) | 06-Apr-23 | Private Purchase | 7,551 | $5.14 | $38,775.10 | < 1% 6.82M to 6.83M | |
| 06-Apr-23 1:16 PM View: | South Cone Investments Limi... 10% Owner | Rani Therapeutics Holdings,... (RANI) | 05-Apr-23 | Purchase | 7,280 | $5.49 | $39,945.40 | < 1% 6.81M to 6.82M | |
| 06-Apr-23 1:16 PM View: | South Cone Investments Limi... 10% Owner | Rani Therapeutics Holdings,... (RANI) | 04-Apr-23 | Private Purchase | 4,416 | $5.49 | $24,246.50 | < 1% 6.81M to 6.81M | |
| 05-Apr-23 11:48 AM View: | South Cone Investments Limi... 10% Owner | Rani Therapeutics Holdings,... (RANI) | 03-Apr-23 | Private Purchase | 3,587 | $5.23 | $18,748.50 | < 1% 6.8M to 6.81M | |
| 03-Apr-23 2:16 PM View: | South Cone Investments Limi... 10% Owner | Rani Therapeutics Holdings,... (RANI) | 31-Mar-23 | Purchase | 751 | $5.05 | $3,790.75 | < 1% 6.8M to 6.8M | |
| 03-Apr-23 2:16 PM View: | South Cone Investments Limi... 10% Owner | Rani Therapeutics Holdings,... (RANI) | 30-Mar-23 | Private Purchase | 12,230 | $4.79 | $58,582.90 | < 1% 6.79M to 6.8M | |
| 30-Mar-23 2:51 PM View: | South Cone Investments Limi... 10% Owner | Rani Therapeutics Holdings,... (RANI) | 28-Mar-23 | Private Purchase | 3,510 | $5.49 | $19,282.90 | < 1% 6.79M to 6.79M | |
| 29-Mar-23 9:06 PM View: | Sanford Svai S CFO | Rani Therapeutics Holdings,... (RANI) | 27-Mar-23 | Grant | 139,000 | -- | -- | 116% 119.6K to 258.6K | |
| 29-Mar-23 9:12 PM View: | Groen Eric General Counsel | Rani Therapeutics Holdings,... (RANI) | 27-Mar-23 | Grant | 139,000 | -- | -- | 574% 24.22K to 163.22K | |
| 29-Mar-23 8:59 PM View: | Imran Talat CEO Director | Rani Therapeutics Holdings,... (RANI) | 27-Mar-23 | Grant | 353,500 | -- | -- | 389% 90.94K to 444.44K | |
| 29-Mar-23 9:09 PM View: | Hashim Mir Chief Scientific Officer | Rani Therapeutics Holdings,... (RANI) | 27-Mar-23 | Grant | 139,000 | -- | -- | 104% 134.26K to 273.26K | |
| 24-Mar-23 4:05 PM View: | Sanford Svai S CFO | Rani Therapeutics Holdings,... (RANI) | 22-Mar-23 | Payment of Exercise | 3,355 | $5.95 | $19,962.20 | (3%) 122.95K to 119.6K | |
| 24-Mar-23 4:05 PM View: | Groen Eric General Counsel | Rani Therapeutics Holdings,... (RANI) | 22-Mar-23 | Payment of Exercise | 2,498 | $5.95 | $14,863.10 | (9%) 26.71K to 24.22K | |
| 24-Mar-23 4:05 PM View: | Imran Talat CEO Director | Rani Therapeutics Holdings,... (RANI) | 22-Mar-23 | Payment of Exercise | 7,988 | $5.95 | $47,528.60 | (8%) 98.93K to 90.94K | |
| 24-Mar-23 4:05 PM View: | Hashim Mir Chief Scientific Officer | Rani Therapeutics Holdings,... (RANI) | 22-Mar-23 | Payment of Exercise | 4,201 | $5.95 | $24,995.90 | (3%) 138.47K to 134.26K | |
| 22-Mar-23 12:48 PM View: | South Cone Investments Limi... 10% Owner | Rani Therapeutics Holdings,... (RANI) | 21-Mar-23 | Purchase | 3,230 | $6.08 | $19,637.10 | < 1% 6.78M to 6.79M | |
| 22-Mar-23 12:48 PM View: | South Cone Investments Limi... 10% Owner | Rani Therapeutics Holdings,... (RANI) | 20-Mar-23 | Private Purchase | 532 | $6.29 | $3,347.66 | < 1% 6.78M to 6.78M | |
| 20-Mar-23 12:13 PM View: | South Cone Investments Limi... 10% Owner | Rani Therapeutics Holdings,... (RANI) | 17-Mar-23 | Purchase | 2,980 | $6.19 | $18,448.00 | < 1% 6.78M to 6.78M | |
| 20-Mar-23 12:13 PM View: | South Cone Investments Limi... 10% Owner | Rani Therapeutics Holdings,... (RANI) | 16-Mar-23 | Private Purchase | 1,325 | $6.07 | $8,045.40 | < 1% 6.78M to 6.78M | |
| 15-Mar-23 11:15 AM View: | South Cone Investments Limi... 10% Owner | Rani Therapeutics Holdings,... (RANI) | 13-Mar-23 | Private Purchase | 2,463 | $6.14 | $15,120.60 | < 1% 6.78M to 6.78M | |
| 10-Mar-23 2:48 PM View: | South Cone Investments Limi... 10% Owner | Rani Therapeutics Holdings,... (RANI) | 09-Mar-23 | Purchase | 3,730 | $6.56 | $24,487.10 | < 1% 6.77M to 6.78M | |
| 10-Mar-23 2:48 PM View: | South Cone Investments Limi... 10% Owner | Rani Therapeutics Holdings,... (RANI) | 08-Mar-23 | Private Purchase | 1,702 | $6.58 | $11,202.20 | < 1% 6.77M to 6.77M | |
| 08-Mar-23 10:10 AM View: | South Cone Investments Limi... 10% Owner | Rani Therapeutics Holdings,... (RANI) | 06-Mar-23 | Private Purchase | 1,100 | $6.39 | $7,031.97 | < 1% 6.77M to 6.77M | |
| 06-Mar-23 3:26 PM View: | South Cone Investments Limi... 10% Owner | Rani Therapeutics Holdings,... (RANI) | 02-Mar-23 | Private Purchase | 3,900 | $6.31 | $24,609.00 | < 1% 6.77M to 6.77M | |
| 02-Mar-23 12:14 PM View: | South Cone Investments Limi... 10% Owner | Rani Therapeutics Holdings,... (RANI) | 28-Feb-23 | Private Purchase | 711 | $6.30 | $4,478.30 | < 1% 6.76M to 6.77M | |
| 28-Feb-23 11:24 AM View: | South Cone Investments Limi... 10% Owner | Rani Therapeutics Holdings,... (RANI) | 27-Feb-23 | Purchase | 3,541 | $6.30 | $22,308.30 | < 1% 6.76M to 6.76M | |
| 28-Feb-23 11:24 AM View: | South Cone Investments Limi... 10% Owner | Rani Therapeutics Holdings,... (RANI) | 24-Feb-23 | Private Purchase | 5,451 | $6.09 | $33,179.70 | < 1% 6.76M to 6.76M |
